Skip to main content

Penbraya Disease Interactions

There is 1 disease interaction with Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316)).

Moderate

Meningococcal conjugate vaccine (applies to Penbraya) GBS

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Guillain-Barre Syndrome

Persons previously diagnosed with Guillain-Barre syndrome (GBS) may be at increased risk of GBS following receipt of meningococcal conjugate vaccine. The decision to give this vaccine should take into account the potential benefits and risks.

References

  1. (2024) "Product Information. Penbraya (cvx 316) (meningococcal group ACWY conjugate-group B vaccine (cvx 316))." Pfizer U.S. Pharmaceuticals Group

Penbraya drug interactions

There are 288 drug interactions with Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316)).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer